AI PRODUCTS ❯
Vida Diagnostic
Lung Cancer Resection Evaluation - Vida

Parent Company:

Vida Diagnostic

Product:

Lung Cancer Resection Evaluation - Vida

For borderline lung cancer resection patients, predicting post-operative lung function (PPO) is critical in determining surgical suitability; however, today’s methodologies are rudimentary (segment counting), expensive (vertilation perfusion scan), and carry imprecision of 18-21%1. VIDA's Lung Cancer Resection Evaluation report provides Quantitative CT (QCT) analysis at the segmental level to aid in FEV1PPO calculations.

Key Data Included

  • Lung Density as measured by Low Attenuation (LAA)
  • Disease Heterogeneity between lobes
  • Regional and Global Volume
  • Residual Lung Volume calculations
  • Residual LAA %

anatomy
Chest
Subspecialty
Lung
Modality
CT
N/A - Unknown
Research
Airway Mapping - Vida
Anatomy:
Chest
subspeciality:
Lung
Modality:
CT
Approved
Approved
details
COPD and Asthma Assessment - Vida
Anatomy:
Chest
subspeciality:
Lung
Modality:
CT
Approved
Approved
details
Lung Volume Analysis - Vida
Anatomy:
Chest
subspeciality:
Lung
Modality:
CT
Approved
Approved
details